Test Code LAB3500 Thyroglobulin, Tumor Marker, Serum
Useful For
Follow-up of patients with differentiated thyroid cancers after thyroidectomy and radioactive iodine ablation
Reporting Name
Thyroglobulin, Tumor MarkerSpecimen Type
Serum RedOrdering Guidance
For accurate analysis of patients who are known to be thyroglobulin antibody positive, order TGMS / Thyroglobulin Mass Spectrometry, Serum.
Specimen Required
Patient Preparation: For 12 hours before specimen collection, patient should not take multivitamins or dietary supplements (eg, hair, skin, and nail supplements) containing biotin (vitamin B7).
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Red top
Acceptable: None (serum gel/SST are not acceptable)
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Serum Red | Refrigerated (preferred) | 7 days |
Frozen | 30 days | |
Ambient | 7 days |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | OK |
Gross icterus | Reject |
Reference Values
Thyroglobulin Tumor Marker
≤33 ng/mL
Thyroglobulin Antibody:
<1.8 IU/mL
Reference values apply to all ages.
Cautions
The test is most sensitive for detection of thyroid cancer recurrence when patients are off thyroid replacement long enough to have an elevated thyrotropin (TSH) prior to collecting the specimen. This test also can be used to follow patients with normal TSH; however, thyroglobulin (Tg) values from specimens with high TSH should not be compared with values with normal TSH, because TSH stimulation changes the baseline determinations.
Thyroglobulin autoantibodies (TgAb) may interfere with the measurement of Tg. All specimens are prescreened for TgAb, and a comment appended to the report if they are present. Undetectable levels of Tg should be interpreted with caution if TgAb are present. A Tg antibody result of less than 1.8 IU/mL is unlikely to cause clinically significant Tg assay interference. It is recommended that the Tg result be reviewed for concordance with clinical presentation.
In rare cases, some individuals can develop antibodies to mouse or other animal antibodies (often referred to as human anti-mouse antibodies [HAMA] or heterophile antibodies), which may cause interference in some immunoassays. Caution should be used in interpretation of results, and the laboratory should be alerted if the result does not correlate with the clinical presentation.
Specimens with Tg concentrations greater than 250,000 ng/mL may "hook" and appear to have markedly lower levels.
Thyroglobulin and TgAb values determined by different methodologies might vary significantly and cannot be directly compared with one another. Some patients might be antibody-positive by some methods and antibody-negative by others. Comparing values from different methods might lead to erroneous clinical interpretation.
Day(s) Performed
Monday through Saturday
Report Available
1 to 3 daysPerforming Laboratory

Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
84432
86800
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
HTG2 | Thyroglobulin, Tumor Marker | 57780-9 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
TGAB2 | Thyroglobulin Antibody, S | 56536-6 |
HTGN2 | Thyroglobulin, Tumor Marker, S | 3013-0 |
HTG2I | Thyroglobulin Interpretation | 69053-7 |
NY State Approved
YesMethod Name
Immunoenzymatic Assay
Forms
If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:
-General Request (T239)
-Oncology Test Request (T729)
-Renal Diagnostics Test Request (T830)